158 related articles for article (PubMed ID: 37430263)
1. TREC mediated oncogenesis in human immature T lymphoid malignancies preferentially involves ZFP36L2.
Balducci E; Steimlé T; Smith C; Villarese P; Feroul M; Payet-Bornet D; Kaltenbach S; Couronné L; Lhermitte L; Touzart A; Dourthe ME; Simonin M; Baruchel A; Dombret H; Ifrah N; Boissel N; Nadel B; Macintyre E; Cieslak A; Asnafi V
Mol Cancer; 2023 Jul; 22(1):108. PubMed ID: 37430263
[TBL] [Abstract][Full Text] [Related]
2. In vivo reinsertion of excised episomes by the V(D)J recombinase: a potential threat to genomic stability.
Vanura K; Montpellier B; Le T; Spicuglia S; Navarro JM; Cabaud O; Roulland S; Vachez E; Prinz I; Ferrier P; Marculescu R; Jäger U; Nadel B
PLoS Biol; 2007 Mar; 5(3):e43. PubMed ID: 17298184
[TBL] [Abstract][Full Text] [Related]
3. Recent thymic emigrants and prognosis in T- and B-cell childhood hematopoietic malignancies.
Petridou E; Klimentopoulou AE; Moustaki M; Kostrikis LG; Hatzakis A; Trichopoulos D
Int J Cancer; 2002 Sep; 101(1):74-7. PubMed ID: 12209591
[TBL] [Abstract][Full Text] [Related]
4. Oncogenesis of T-ALL and nonmalignant consequences of overexpressing intracellular NOTCH1.
Li X; Gounari F; Protopopov A; Khazaie K; von Boehmer H
J Exp Med; 2008 Nov; 205(12):2851-61. PubMed ID: 18981238
[TBL] [Abstract][Full Text] [Related]
5. Oncogenetic landscape of T-cell lymphoblastic lymphomas compared to T-cell acute lymphoblastic leukemia.
Bontoux C; Simonin M; Garnier N; Lhermitte L; Touzart A; Andrieu G; Bruneau J; Lengliné E; Plesa A; Boissel N; Baruchel A; Bertrand Y; Molina TJ; Macintyre E; Asnafi V
Mod Pathol; 2022 Sep; 35(9):1227-1235. PubMed ID: 35562412
[TBL] [Abstract][Full Text] [Related]
6. T-cell lymphoblastic lymphoma and leukemia: different diseases from a common premalignant progenitor?
Kroeze E; Loeffen JLC; Poort VM; Meijerink JPP
Blood Adv; 2020 Jul; 4(14):3466-3473. PubMed ID: 32722786
[TBL] [Abstract][Full Text] [Related]
7. MYC fails to efficiently shape malignant transformation in T-cell acute lymphoblastic leukemia.
Loosveld M; Bonnet M; Gon S; Montpellier B; Quilichini B; Navarro JM; Crouzet T; Goujart MA; Chasson L; Morgado E; Picard C; Hernandez L; Fossat C; Gabert J; Michel G; Nadel B; Payet-Bornet D
Genes Chromosomes Cancer; 2014 Jan; 53(1):52-66. PubMed ID: 24249258
[TBL] [Abstract][Full Text] [Related]
8. Diverse mutations and structural variations contribute to Notch signaling deregulation in paediatric T-cell lymphoblastic lymphoma.
Salmerón-Villalobos J; Ramis-Zaldivar JE; Balagué O; Verdú-Amorós J; Celis V; Sábado C; Garrido M; Mato S; Uriz J; Ortega MJ; Gutierrez-Camino A; Sinnett D; Illarregi U; Carron M; Regueiro A; Galera A; Gonzalez-Farré B; Campo E; Garcia N; Colomer D; Astigarraga I; Andrés M; Llavador M; Martin-Guerrero I; Salaverria I
Pediatr Blood Cancer; 2022 Nov; 69(11):e29926. PubMed ID: 36000950
[TBL] [Abstract][Full Text] [Related]
9. The molecular basis of T cell acute lymphoblastic leukemia.
Van Vlierberghe P; Ferrando A
J Clin Invest; 2012 Oct; 122(10):3398-406. PubMed ID: 23023710
[TBL] [Abstract][Full Text] [Related]
10. T-cell lymphoblastic lymphoma shows differences and similarities with T-cell acute lymphoblastic leukemia by genomic and gene expression analyses.
Basso K; Mussolin L; Lettieri A; Brahmachary M; Lim WK; Califano A; Basso G; Biondi A; Cazzaniga G; Rosolen A
Genes Chromosomes Cancer; 2011 Dec; 50(12):1063-75. PubMed ID: 21987448
[TBL] [Abstract][Full Text] [Related]
11. T cell receptor excision circles (TRECs) and kappa-deleting recombination excision circles (KRECs) as markers of early T cell and B cell immune recovery after haematopoietic stem cell transplantation (HSCT).
Elghazawy M; Talkhan H; Ghareeb H; Samaha D; El-Zimaity M; Salem L
Egypt J Immunol; 2022 Oct; 29(4):46-57. PubMed ID: 36197153
[TBL] [Abstract][Full Text] [Related]
12. Molecular and phenotypic characterization of an early T-cell precursor acute lymphoblastic lymphoma harboring PICALM-MLLT10 fusion with aberrant expression of B-cell antigens.
Khurana S; Melody ME; Ketterling RP; Peterson JF; Luoma IM; Vazmatzis G; Tun HW; Foran JM; Jiang L
Cancer Genet; 2020 Jan; 240():40-44. PubMed ID: 31739126
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of the shortest isoform of histone demethylase LSD1 primes hematopoietic stem cells for malignant transformation.
Wada T; Koyama D; Kikuchi J; Honda H; Furukawa Y
Blood; 2015 Jun; 125(24):3731-46. PubMed ID: 25904247
[TBL] [Abstract][Full Text] [Related]
14. T-Cell Acute Lymphoblastic Leukemia: Biomarkers and Their Clinical Usefulness.
Bardelli V; Arniani S; Pierini V; Di Giacomo D; Pierini T; Gorello P; Mecucci C; La Starza R
Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440292
[TBL] [Abstract][Full Text] [Related]
15. T-cell acute lymphoblastic leukemia from miRNA perspective: Basic concepts, experimental approaches, and potential biomarkers.
Drobna M; Szarzyńska-Zawadzka B; Dawidowska M
Blood Rev; 2018 Nov; 32(6):457-472. PubMed ID: 29703513
[TBL] [Abstract][Full Text] [Related]
16. Immature MEF2C-dysregulated T-cell leukemia patients have an early T-cell precursor acute lymphoblastic leukemia gene signature and typically have non-rearranged T-cell receptors.
Zuurbier L; Gutierrez A; Mullighan CG; Canté-Barrett K; Gevaert AO; de Rooi J; Li Y; Smits WK; Buijs-Gladdines JG; Sonneveld E; Look AT; Horstmann M; Pieters R; Meijerink JP
Haematologica; 2014 Jan; 99(1):94-102. PubMed ID: 23975177
[TBL] [Abstract][Full Text] [Related]
17. Unraveling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis.
Agraz-Doblas A; Bueno C; Bashford-Rogers R; Roy A; Schneider P; Bardini M; Ballerini P; Cazzaniga G; Moreno T; Revilla C; Gut M; Valsecchi MG; Roberts I; Pieters R; De Lorenzo P; Varela I; Menendez P; Stam RW
Haematologica; 2019 Jun; 104(6):1176-1188. PubMed ID: 30679323
[TBL] [Abstract][Full Text] [Related]
18. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.
Durinck K; Wallaert A; Van de Walle I; Van Loocke W; Volders PJ; Vanhauwaert S; Geerdens E; Benoit Y; Van Roy N; Poppe B; Soulier J; Cools J; Mestdagh P; Vandesompele J; Rondou P; Van Vlierberghe P; Taghon T; Speleman F
Haematologica; 2014 Dec; 99(12):1808-16. PubMed ID: 25344525
[TBL] [Abstract][Full Text] [Related]
19. PID comes full circle: applications of V(D)J recombination excision circles in research, diagnostics and newborn screening of primary immunodeficiency disorders.
van Zelm MC; van der Burg M; Langerak AW; van Dongen JJ
Front Immunol; 2011; 2():12. PubMed ID: 22566803
[TBL] [Abstract][Full Text] [Related]
20. ZEB2 and LMO2 drive immature T-cell lymphoblastic leukemia via distinct oncogenic mechanisms.
Goossens S; Wang J; Tremblay CS; De Medts J; T'Sas S; Nguyen T; Saw J; Haigh K; Curtis DJ; Van Vlierberghe P; Berx G; Taghon T; Haigh JJ
Haematologica; 2019 Aug; 104(8):1608-1616. PubMed ID: 30679322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
